Search research articles
Contact Us
Filters
Showing results (321-330 of 468) with videos related to
Page
of 47
Sort By:
World Neurosurgery
|
February 7, 2021
Gray Matter Atrophy: The Impacts of Resective Surgery and Vagus Nerve Stimulation in Drug-Resistant Epilepsy
Jordan Lam, Ryan P Cabeen, Runi Tanna, et al.
Biotechnology Progress
|
August 21, 2015
Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes
Marcos F Q Sousa, Marta M Silva, Daniel Giroux, et al.
Public Health Reports (Washington, D.C. : 1974)
|
June 18, 2021
Protecting Privacy and Transforming COVID-19 Case Surveillance Datasets for Public Use
Brian Lee, Brandi Dupervil, Nicholas P Deputy, et al.
JACC. Advances
|
June 28, 2024
Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic Cardiomyopathy
Mason Zhu, Klevin Roger L Reyes, Gizem Bilgili, et al.
Orphanet Journal of Rare Diseases
|
December 22, 2014
Skin fibroblasts from individuals with Chediak-Higashi Syndrome (CHS) exhibit hyposensitive immunogenic response
Le Wang, Kamila Rosamilia Kantovitz, Andrew Robert Cullinane, et al.
Epilepsy Research
|
October 7, 2017
Preventable complications in epilepsy admissions: The "July effect"
Natalie S Pierson, Daniel R Kramer, Timothy Wen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 2, 2020
A Streamlined CyTOF Workflow To Facilitate Standardized Multi-Site Immune Profiling of COVID-19 Patients
Daniel Geanon, Brian Lee, Geoffrey Kelly, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
November 20, 2025
FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experience
Jose Tinajero, Dat Ngo, Brian Lee, et al.
NEJM Evidence
|
August 30, 2023
Quantifying Treatment Effects in Trials with Multiple Event-Time Outcomes
Brian Lee Claggett, Zachary R McCaw, Lu Tian, et al.
Bioengineering (Basel, Switzerland)
|
March 24, 2022
Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
Brian Lee, Sunghoon Jung, Yas Hashimura, et al.
Page
of 47
Search research articles
Search
Showing results (321-330 of 468) with videos related to
Sort By:
Page
of 47
World Neurosurgery
|
February 7, 2021
Gray Matter Atrophy: The Impacts of Resective Surgery and Vagus Nerve Stimulation in Drug-Resistant Epilepsy
Jordan Lam, Ryan P Cabeen, Runi Tanna, et al.
Biotechnology Progress
|
August 21, 2015
Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes
Marcos F Q Sousa, Marta M Silva, Daniel Giroux, et al.
Public Health Reports (Washington, D.C. : 1974)
|
June 18, 2021
Protecting Privacy and Transforming COVID-19 Case Surveillance Datasets for Public Use
Brian Lee, Brandi Dupervil, Nicholas P Deputy, et al.
JACC. Advances
|
June 28, 2024
Medical Therapies to Improve Left Ventricular Outflow Obstruction and Diastolic Function in Hypertrophic Cardiomyopathy
Mason Zhu, Klevin Roger L Reyes, Gizem Bilgili, et al.
Orphanet Journal of Rare Diseases
|
December 22, 2014
Skin fibroblasts from individuals with Chediak-Higashi Syndrome (CHS) exhibit hyposensitive immunogenic response
Le Wang, Kamila Rosamilia Kantovitz, Andrew Robert Cullinane, et al.
Epilepsy Research
|
October 7, 2017
Preventable complications in epilepsy admissions: The "July effect"
Natalie S Pierson, Daniel R Kramer, Timothy Wen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 2, 2020
A Streamlined CyTOF Workflow To Facilitate Standardized Multi-Site Immune Profiling of COVID-19 Patients
Daniel Geanon, Brian Lee, Geoffrey Kelly, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
November 20, 2025
FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experience
Jose Tinajero, Dat Ngo, Brian Lee, et al.
NEJM Evidence
|
August 30, 2023
Quantifying Treatment Effects in Trials with Multiple Event-Time Outcomes
Brian Lee Claggett, Zachary R McCaw, Lu Tian, et al.
Bioengineering (Basel, Switzerland)
|
March 24, 2022
Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
Brian Lee, Sunghoon Jung, Yas Hashimura, et al.
Page
of 47